Vascular Solutions (VASC) Tops Q3 EPS by 1c; Issues Solid Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Vascular Solutions Reports Third Quarter Results
October 24, 2016 4:05 PM EDTQ3 revenue increased 13% to $41.8 million, near the top end of guidanceQ3 GAAP EPS of $0.31, at the top end of guidanceGuidance for Q4 revenue set at $43.0-$44.0 million, representing growth of 14% at the midpointGuidance for Q4 GAAP EPS set at $0.34-$0.36Preliminary guidance for 2017 set at revenue of $183-$187 million and GAAP EPS of $1.44-$1.48
MINNEAPOLIS, Oct. 24, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today reported financial... More
